Krishnan Ramaswamy
10PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 24, 2025
Survival benefit associated with first-line androgen receptor pathway inhibitors for de novo metastatic castration-sensitive prostate cancer.Stephen J Freedland, Agnes Hong, Nader El-Chaar
|Sep 13, 2024
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment.Stephen J Freedland, Wei Gao, Angela Lax
|Apr 02, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.Daniel J George, Neeraj Agarwal, Krishnan Ramaswamy
|Mar 28, 2024
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer.Daniel J George, Krishnan Ramaswamy, Hongbo Yang
|Dec 14, 2022
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting.Stephen J Freedland, Agnes Hong, Nader El-Chaar
|Jul 15, 2022
Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate.Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang
Pageof 2
Frequent Collaborators
5 joint publications
Stephen J Freedland
3 joint publications
Scott T Tagawa
3 joint publications
Daniel J George
2 joint publications
Jasmina Ivanova
1 joint publications
Andrew J Armstrong
1 joint publications
Tomasz M Beer
1 joint publications
Maha Hussain
1 joint publications
Fred Saad
1 joint publications
Jack Mardekian
1 joint publications
Alicia K Morgans
